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Abstract
Background: Falls in hospitals are common, resulting in injury and anxiety to patients, and large
costs to NHS organisations. More than half of all in-patient falls in elderly people in acute care
settings occur at the bedside, during transfers or whilst getting up to go to the toilet. In the majority
of cases these falls are unwitnessed. There is insufficient evidence underpinning the effectiveness of
interventions to guide clinical staff regarding the reduction of falls in the elderly inpatient. New
patient monitoring technologies have the potential to offer advances in falls prevention. Bedside
sensor equipment can alert staff, not in the immediate vicinity, to a potential problem and avert a
fall. However no studies utilizing this assistive technology have demonstrated a significant reduction
in falls rates in a randomised controlled trial setting.
Methods/Design: The research design is an individual patient randomised controlled trial of
bedside chair and bed pressure sensors, incorporating a radio-paging alerting mode to alert staff to
patients rising from their bed or chair, across five acute elderly care wards in Nottingham
University Hospitals NHS Trust. Participants will be randomised to bedside chair and bed sensors
or to usual care (without the use of sensors). The primary outcome is the number of bedside in-
patient falls.
Discussion: The REFINE study is the first randomised controlled trial of bedside pressure sensors
in elderly inpatients in an acute NHS Trust. We will assess whether falls can be successfully and
cost effectively reduced using this technology, and report on its acceptability to both patients and
staff.
Trial Registration: ISRCTN trial number: ISRCTN44972300.
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Background
Falls in hospitals are common, ranging from 3 to 14 for
every 1,000 bed days [1]. Over 200,000 falls were reported
to the National Patient Safety Agency's (NPSA) National
Reporting and Learning System (NRLS) in the 12 months
from September 2005 to August 2006, with falls data
being reported from 98% of organisations providing in-
patient services [2]. In-patient falls result in injury and
anxiety to patients and large costs to NHS organisations,
including the costs of treating injuries, increased hospital
stay, complaints and litigation [3-5].
Elderly in-patients are at particular risk of falling with the
incidence of falls being almost triple that for community-
dwelling older people [6]. Several factors contribute to
this including; age, a history of falling, impaired mobility
and special toileting needs. People with dementia are
more likely than those without it to require hospital
admission, and are at least twice as likely to fall [7-9]. Up
to 30% of in-patient falls occur during the first 48 hours
of the patients' admission and 75% of in-patient falls
occur in the first two weeks of hospital stay [7,10,11].
Our hospital audit data are consistent with published data
[2] and has shown that more than half (53%) of all in-
patient falls in elderly people in acute care settings
occurred at the bedside, during transfers or whilst getting
up to go to the toilet. In the majority of cases these falls
were unwitnessed. Where patients had been advised to
call for assistance they were often reluctant to ask for help
as they "did "not want to bother the nurses" or were una-
ble to do so because of cognitive impairment.
Prevention of falls is a priority for NHS policy makers and
practitioners. The Healthcare Commission has used falls
prevention as a focus for inspecting compliance under
patient safety [12]. Despite our increasing knowledge of
the aetiology and epidemiology of falls, there is a dearth
of evidence for effective falls prevention in hospitals [13-
15]. There is good evidence for falls prevention in the
community dwelling elderly [16-18], but these findings
are unlikely to generalise to the acute hospital setting.
Advances in telecare afford innovative approaches to the
reduction of falls. Assistive technology such as bed and
bedside chair alarms, which alert nearby staff that a per-
son is attempting to leave the bed or chair, are increasingly
being used in the NHS [19]. However there is a lack of evi-
dence underpinning the use of such systems. Of the few
studies that have been published, none have demon-
strated a significant reduction in falls rates in a ran-
domised controlled trial setting [20,21].
The current study will address shortcomings in the evi-
dence base. We will assess whether falls can be success-
fully and cost effectively reduced using pressure sensor-
pager technology in a randomised controlled trial.
Objectives
Main research hypothesis
The hypothesis to be tested is that the use of a pressure
sensor alert system, incorporating a radio-paging alerting
mode to alert staff to patients rising from their bed or
chair, can decrease the number of bedside falls, in older
people hospitalized in an acute care setting.
Secondary research hypotheses
1. There is a beneficial effect of pressure sensors upon
health outcomes (transfer and mobility, fear of falling,
quality of life, length of hospital stay and residential status
on discharge) in hospitalised older people.
2. That the intervention above is cost-effective compared
to usual care from a secondary care NHS perspective.
3. That there are groups of patients in whom the health or
economic benefits from the intervention are greatest.
4. That the sensor system is acceptable to staff and patients
and practical for use in an acute hospital setting.
Methods/Design
The study is a pragmatic parallel-arm randomised control-
led trial. Subjects are randomised either to receive bed and
chair sensor equipment, or standard care (control arm),
see Figure 1 (Flow of participants through the study).
Setting
Five acute older persons' care wards at Nottingham Uni-
versity Hospitals NHS Trust (NUH).
Participants
All patients admitted to five older persons' care wards are
eligible for inclusion into the trial. Patients will be
excluded from the study if they were permanently bed
bound prior to admission, moribund/unconscious, or
receiving end of life care on admission, or if they have pre-
viously been included in the study in an earlier admission.
Ethics and consent
The study is executed in accordance with the principles
laid down in the Helsinki Declaration [22]. This study was
approved by Nottingham Research Ethics Committee 1
on the 23rd May 2008 (Reference: 07HC006; MREC: 08/
H0403/40).
Written, informed consent is obtained, in accordance with
International Conference on Harmonisation Guidelines
for Good Clinical Practice (ICH GCP) [23]. In patients
who are confused (dementia/delirium such that the sub-Trials 2009, 10:83 http://www.trialsjournal.com/content/10/1/83
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ject cannot understand the nature of consenting to a
research study and the study process), consent is obtained
by carers or other proxies including staff, following the
established framework of Berghmans, used in previous
ethically approved studies in older persons with dementia
[24].
Intervention
Those participants randomised to the intervention arm of
the trial will receive bedside chair and bed pressure sen-
sors for the duration of their ward admission.
Each sensor device consists of a flexible pressure pad
enveloped in thin foam encased in a durable plastic coat-
Flow of participants through the study Figure 1
Flow of participants through the study.Trials 2009, 10:83 http://www.trialsjournal.com/content/10/1/83
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ing such that it confirms to hospital infection control pol-
icies. The bed sensor (760 mm × 250 mm × 3 mm) is
placed between the bed mattress and the base of the bed
in a horizontal position directly under the hip region. The
chair sensor (360 mm × 175 mm × 3 mm) is positioned
on top of the chair base and/or under a cushion.
The sensors detect pressure changes as the patient rises
from the bed or chair, whereafter an alert is sent via radio
page to a handheld pager carried by nursing staff. The
pager provides the location of the call so staff can respond
rapidly and ensure the patient is safe. In this way the sen-
sor system provides an early warning to staff that the
patient has left the bed or chair, and may therefore avert a
potential fall.
Sensor units are leased from Tunstall Ltd. and are CE
marked, complying with the regulatory authorities. Nurs-
ing staff on participating will be trained to use the sensors
prior to trial recruitment. Members of the research team fit
the sensors to the beds and chairs with the sensors left in
place until the participant is discharged.
Sample size
Based on data obtained from our wards during 2005, we
anticipate a rate of bedside falls of 8.0 per 1,000 bed days
in the control group, assuming that 53% of all falls occur
at the bedside and that the average length of stay is 19
days (mean number of falls per patient = 0.15). To detect
a 35% reduction in the rate of bedside falls among the
intervention group, assuming 80% power, alpha = 0.05
and an over dispersion parameter of 1.5 (to allow for non-
independence of falls within individuals), 905 partici-
pants are required in each arm of the trial.
Randomisation
Subjects are allocated to the sensor or control arm using
the web based randomisation service provided by the
Clinical Trials Support Unit, University of Nottingham.
Randomisation is determined by a computer-generated
pseudo-random code using random permuted blocks of
randomly varying size, created by the Nottingham Clini-
cal Trials Unit (CTU) in accordance with their standard
operating procedure (SOP) and held on a secure server,
employing the Stata add-in ralloc [25]. Participants are
allocated with equal probability to the sensor or control
arm of the study. The randomisations are requested
through a PC with internet explorer and internet access.
The system is located on a dedicated secure server within
the University of Nottingham. All communications
between the user's PC and the server are fully encrypted
(secured SSL 128 bit encrypted) and via a unique user-
name and password.
Blinding
In order to mitigate against nurses preferentially giving
attention to patients with sensor equipment (i.e. the inter-
vention arm) as compared to those without equipment
(i.e. the control arm), we wished to find out if the nurses
could be blinded to treatment allocation by the use of
"dummy" (inactive) sensor equipment. To test the feasi-
bility of this, we carried out a pilot study conducted over
two days, with three 2 hour observation periods each day.
Six sensors (4 active and 2 "dummy" sensors) were used
with six patients, with one nurse (blinded to the status of
the sensors) responding over each 2 hour period. Five
nurses were assessed (the fifth nurse on the second day
underwent two periods of observations). Four of the five
nurses successfully identified the "dummy" versus the
active sensors over the observation period. On the basis of
this we concluded that it was not feasible to blind nurses
to dummy verses active sensor, and therefore we decided
not to use dummy sensor equipment with the control arm
patients, who will be randomised to standard care alone.
Any impact upon the standard care of the control group
will be assessed in a qualitative sub study comprising of a
non-participant observational study, and in-depth inter-
views with ward staff.
In order to reduce observer bias, the primary outcome
measure is assessed from hospital incident reporting
forms by a researcher blinded to treatment group alloca-
tion. Secondary outcome participant interviews are con-
ducted away from the bedside so researchers remain
unaware of group allocation. In instances where the
researcher becomes aware of the intervention the partici-
pant has received ("unblinding"), this will be recorded.
A member of the research team, blinded to sensor alloca-
tion, enters trial outcome data. To assess the success of
blinding, those measuring or entering outcome data are
asked to estimate intervention or standard care for each
participant, and this will be compared to actual allocation
at the end of the study.
Outcome measures
Definition of primary and secondary outcome measures
The primary outcome measure is the number of bedside
in-patient falls per 1,000 bed days from time of randomi-
sation until the participant is discharged from the ward.
A bedside fall is defined as an unexpected event in which
the participant comes to rest on the ground, floor or lower
level in the area around the bedside, with the bedside
being defined as the area encompassed by the curtained
area surrounding the bed. For participants in side rooms,
the bedside is defined as the area of the room.Trials 2009, 10:83 http://www.trialsjournal.com/content/10/1/83
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The secondary outcome measures are:
a. Number of injurious in-patient falls per 1,000 bed days,
defined as falls resulting in abrasion, bruise, swelling, cut,
laceration, dislocation, fracture or muscle sprain or strain.
b. Length of hospital stay.
c. Residential status on discharge.
d. Transfer/mobility score and activities of daily living,
measured using the Barthel Index [26].
e. Fear of falling, measured using the Modified Falls Effi-
cacy Scale (mFES) [27] to ascertain any differential fear of
falling in the two participant groups due to an increased
awareness of a potential for a fall, or a greater sense of
safety arising from sensor use.
f. Health related quality of life, measured using the EURO-
QOL EQ-5D [28].
g. Participant and staff experience of using bed and chair
sensors. This sub-study will be reported separately.
Ascertainment of outcomes (see Table 1 Data Collection Points)
(a) baseline data
The baseline data collected at recruitment originates from
face to face interview between researcher and patient, the
patient's medical and nursing notes, and/or carer.
Baseline data includes:
a. Demographic and residential details, reason for admis-
sion, time since admission.
b. Any previous history of falls, and any resulting frac-
tures.
c. Mobility and transfer before the illness that precipitated
admission, and at the time of recruitment (measured by
the Barthel ADL index).
d. 30 point Mini Mental Stare examination (MMSE).
e. Health related quality of life measured using the Euro-
Qol EQ-5D.
(b) follow up data
Follow up data are collected one day prior or on the day
of discharge.
Follow up data includes:
a. Falls, ascertained from hospital incident reporting
forms. The use of these incident forms in NUH to record
falls is mandatory and enforced by clinical governance
processes. Members of the research team collect copies of
hospital incident reporting forms from participating
wards. Data such as fall event, time, and place, injuries
sustained and subsequent actions taken are recorded.
Where a medical opinion has been requested, the out-
come is recorded, together with any investigations
requested. In addition, aggregated, anonymzed data on
falls will be collected from hospital incident reporting
forms for the trial wards for the 12 month period prior to
the trial commencing. The rate of falls in the period prior
to the trial commencing will be compared with the con-
trol arm rate of falls during the trial to explore whether the
use of sensors increases the rate of falls in the control arm.
b. Transfer/mobility and activities of daily living (Barthel
ADL). This information is ascertained from the partici-
pant or carer, and/or their medical and nursing notes.
c. Quality of life (EuroQol EQ-5D) ascertained by partici-
pant interview. Where a participant is unable to partici-
pate in an interview, health related quality of life is
ascertained from the carer and named nurse.
d. Fear of falling (mFES), ascertained by participant inter-
view. Where a participant is unable to take part in an inter-
view due to poor cognitive ability, this assessment is
coded appropriately and excluded from analysis.
e. Mini Mental State Examination (MMSE), through par-
ticipant interview. The baseline assessment does not
account for any acute delirium secondary to the patient's
condition on hospitalization, which may improve with
treatment. The change in delirium may have an effect on
the risk of falling.
f. Length of stay and residential status on discharge, ascer-
tained from medical records.
Data on resource use will be collected for the economic
analysis and will include the costs of investigations and
interventions arising from any fall whilst in hospital and
Table 1: Data Collection Points
*Data collection Baseline Discharge
Subject demographics X
Previous falls/medical history X
Cognitive ability (30 Point MMSE) XX
Quality of Life (EuroQol EQ-5D) XX
Activities of daily living (Barthel Score) XX
Discharge Destination X
Length of stay X
Fear of Falling Questionnaire (mFES) X
Total number of in-patient falls
(collected at the time of the index event)
XTrials 2009, 10:83 http://www.trialsjournal.com/content/10/1/83
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the length of stay. These data will be obtained from the
medical records. Unit costs will be derived from pub-
lished sources. The cost of the intervention will include
rental costs, plus costs of any sensor failures and cost of
installing, cleaning, and responding to sensor alarms.
Nursing staff on each ward will be asked to record sensor
problems and reasons for sensor removal.
Nurse time taken to respond to sensor alarms will be
ascertained from an observational study to measure the
content and process fidelity of the intervention. The
researchers fitting the bed sensors record the length of
time taken to fit sensors.
Measuring content and process fidelity of the intervention
It is important to be able to demonstrate the extent to
which the bed sensors are used in the study (content fidel-
ity) and the way in which they were used (process fidel-
ity). We record the number of participants who do not
receive the allocated intervention and reasons for this.
Nursing and research staff are asked to record sensor prob-
lems and reasons for sensor removal. In order to assess
process fidelity, an observational study will be conducted
to monitor nurse response rates and time taken to
respond, false alarms and improper use of the sensor (e.g.
not re-setting the transmitter after an alert). Staffing levels
will also be recorded for observation periods to explore
whether ability to respond varies with staffing levels. An
observer will be provided with a pager identical to those
provided to the nurses and will record each alert, the
response to each alert, the time taken to respond, the time
taken to attend to the patient, whether it was a false alarm
or not and improper use of the sensor. Observations will
be undertaken over a random sample of days and time
periods (two days every 6 months), covering each of the
five wards, over the study period.
Withdrawals
Participants are free to withdraw from the trial at any
stage. Participants, who decide to withdraw once recruited
to the study, if allocated to a sensor, will have the sensor
removed and further data collection from that point
stopped. Participants, if allocated to a sensor, in whom it
is deemed are at risk of harm resulting from the sensor
equipment (for example in cases of confusion where the
participant mis-handles the sensor equipment), will have
the sensor removed and further data collection from that
point stopped.
Analysis
Quantitative analysis
Analyses will be undertaken on an intention to treat.
Intention to treat analysis is defined in this study as an a
priori plan to analyse the data according to the groups to
which the subjects were randomised regardless of the
treatment they received.
Fall rates for each group will be expressed as number of
bedside falls per 1,000 bed days. The number of bedside
falls per patient will be compared between groups using
Poisson regression allowing for over dispersion, with
length of stay in days as an offset. Crude models contain-
ing intervention group only will be fitted initially, whilst
additional models will adjust for the effects of age, MMSE
and mobility/transfer scores. Interactions between each of
these three variables and treatment group with respect to
our primary and secondary outcome measures will also be
examined, with covariates dichotomised where necessary.
For other secondary outcome measures, groups will be
compared using the independent samples t-test for con-
tinuous outcomes (or Mann-Whitney U test if assump-
tions for using the t-test are not satisfied following
appropriate transformations of the data) and the chi-
square test for binary/categorical outcomes. The rate of
falls in the trial wards in the 12 months prior to the trial
commencing will be compared with the rate of falls in the
control arm during the trial using Poisson regression,
allowing for overdispersion as appropriate. A significance
level of p < 0.05 will be used for all analyses.
Health economic analysis
A cost-effectiveness and cost-utility analysis will be per-
formed using established methods [29]. The comparative
analysis will be undertaken from a secondary care NHS
perspective capturing direct secondary care health service
costs and benefits over the study period. In addition to
measuring the cost of the intervention, the resources con-
sumed in the two arms of the study are likely to differ as
there is the potential for differential rates of investigations
and treatments, and differential lengths of stay in hospi-
tal. Resources will be valued using published unit cost
data or where needed using locally derived unit costs. In
this study we will use falls prevented as the effectiveness
measure and change in utility as measured using the Euro-
Qol EQ-5D as baseline and discharge [30].
An incremental economic evaluation comparing the sen-
sor group to the standard care will be undertaken to esti-
mate mean incremental cost-effectiveness. If one group is
clearly dominant (less costly and more effective) a recom-
mendation will be made. If non-dominance occurs (that
is if costs are greater and the intervention is more effective
or if the intervention is cheaper and less effective), an
incremental cost-effectiveness ratio will be produced.
Probabilistic sensitivity analysis will be undertaken to test
the robustness of the results. The confidence region
around the incremental cost effectiveness ratio will beTrials 2009, 10:83 http://www.trialsjournal.com/content/10/1/83
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estimated using appropriate statistical techniques such as
the non-parametric bootstrap method. This stochastic
analysis will enable cost effectiveness acceptability curves
and a cost effectiveness acceptability froniter to be pro-
duced [31] illustrating the uncertainty surrounding the
optimal decision. Estimates of the incremental cost, incre-
mental cost effectiveness and the uncertainty around
these estimates will enable us to examine the implications
of rolling out sensors nationally.
Project management, governance and administration
The trial is undertaken in accordance with the Standard
Operating Procedures of the Clinical Trials Support Unit
of the University of Nottingham and the International
Conference on Harmonisation Guidelines for Good Clin-
ical Practice in Clinical Trials [23].
The day-to-day management of the trial is the responsibil-
ity of the research lead, including research staff training
and management. The study finance, documentation
(such as assessment forms and operating procedures),
data recording and storage is managed by the research
lead, who also monitors progress in respect of project
milestones (see Table 2, Project milestones for the study)
and provides appropriate reports to the Trial Management
Group and Trial Steering Committee. The principal inves-
tigator will instigate audits of procedures as required and
takes overall responsibility for any protocol changes
throughout the study.
A Trial Management Group chaired by the principle inves-
tigator, comprising investigators, research staff and
patient representatives, monitors all aspects of the con-
duct and progress of the trial, ensures that the protocol is
adhered to, and will take appropriate action to safeguard
participants and the quality of the trial.
A Trial Steering Committee, comprising the trial manage-
ment group and three external experts (one of whom acts
as chair) has been established to ensure the study govern-
ance and conduct complies with good clinical practice
guidance.
A sub-group of the trial steering committee, the Data
Monitoring and Ethics Committee comprising two of the
external members of the steering group (including the
steering group chair) and a statistician independent to the
study, will receive adverse event forms electronically and
will meet as required in the event of an excessive serious
adverse event rate or if other information is reported to it
which raises concern over the safe conduct of the trial.
Confidentiality and data storage
All participant questionnaires and case note abstraction
forms are stored in locked cabinets, identified by a unique
participant identifier. Consent forms and other docu-
ments including the participant's name are stored sepa-
rately from questionnaires and other trial documents in
locked cabinets.
All computer databases include the unique participant
identifier and not the name and address of the participant.
The database is stored on a secure dedicated clinical trials
server at the University of Nottingham. The server itself is
located within in a locked server room, with restricted key
access to authorised individuals. Users log into the data-
base system by entering their username and password via
a secure encrypted connection (https protocol/128 bit SSL
encryption). The database automatically maintains an
audit trail, which records all activity. Data will be stored
for 10 years.
Discussion
The REFINE study proposed is the largest single interven-
tion in inpatient falls, in the UK, as far as the researchers
are aware. This innovative study is among the first ran-
domised controlled trials to examine the effectiveness and
cost-utility of a bedside sensor-paging system. It will
Table 2: Project milestones for the study.
Project milestones REFINE
2005. "Bed Sensors Reduce In-patient Falls and Hospital Length of Stay" [32]
2005. Health and Social Care Technology Award for the Midlands and East
2006. Planning for a large RCT of inpatient sensors initiated
Dec 2007. Grant awarded by the Research for Patient Benefit Programme of the National Institute for Health Research, UK 
(PB-PG-0107-11112)
May 2008. Ethics approval has been obtained from the Nottingham Research Ethics Committee (reference 07HC006).
Aug 2008. Study commencement.
Sept 2008. Ward staff trained, Pilot of equipment and procedures
Oct 2008. Recruitment commenced
Dec 2010. Recruitment completed
Feb 2011. Last participant discharged
April 2011. Analysis completed
July 2011. PublicationTrials 2009, 10:83 http://www.trialsjournal.com/content/10/1/83
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respond to the dearth of randomised trials to investigate
the impact of telecare upon falls in the elderly. Moreover
it will be conducted with a large number of elderly in-
patients in the challenging environment of a busy acute
NHS Trust. The results will establish whether this moni-
toring system is a cost effective intervention that patients,
acute trusts and other in-patient institutes can utilize and
benefit from.
Publications
All investigators will contribute towards drafting the
paper reporting the main trial findings and all investiga-
tors will be named authors on that paper, providing they
fulfil the Vancouver criteria for authorship. Investigators
wishing to analyze and report other findings from the
study can do so on the agreement of the other investiga-
tors, and the study team will agree authorship for these
papers, subject to the Vancouver criteria for authorship.
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